IBDEI1TC ; ; 17-FEB-2016
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,30802,1,4,0)
 ;;=4^F32.1
 ;;^UTILITY(U,$J,358.3,30802,2)
 ;;=^5003522
 ;;^UTILITY(U,$J,358.3,30803,0)
 ;;=F32.2^^123^1534^19
 ;;^UTILITY(U,$J,358.3,30803,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30803,1,3,0)
 ;;=3^MDD,Single Episode,Severe
 ;;^UTILITY(U,$J,358.3,30803,1,4,0)
 ;;=4^F32.2
 ;;^UTILITY(U,$J,358.3,30803,2)
 ;;=^5003523
 ;;^UTILITY(U,$J,358.3,30804,0)
 ;;=F32.3^^123^1534^14
 ;;^UTILITY(U,$J,358.3,30804,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30804,1,3,0)
 ;;=3^MDD,Single Episode w Psychotic Features
 ;;^UTILITY(U,$J,358.3,30804,1,4,0)
 ;;=4^F32.3
 ;;^UTILITY(U,$J,358.3,30804,2)
 ;;=^5003524
 ;;^UTILITY(U,$J,358.3,30805,0)
 ;;=F32.4^^123^1534^16
 ;;^UTILITY(U,$J,358.3,30805,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30805,1,3,0)
 ;;=3^MDD,Single Episode,In Partial Remission
 ;;^UTILITY(U,$J,358.3,30805,1,4,0)
 ;;=4^F32.4
 ;;^UTILITY(U,$J,358.3,30805,2)
 ;;=^5003525
 ;;^UTILITY(U,$J,358.3,30806,0)
 ;;=F32.5^^123^1534^15
 ;;^UTILITY(U,$J,358.3,30806,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30806,1,3,0)
 ;;=3^MDD,Single Episode,In Full Remission
 ;;^UTILITY(U,$J,358.3,30806,1,4,0)
 ;;=4^F32.5
 ;;^UTILITY(U,$J,358.3,30806,2)
 ;;=^5003526
 ;;^UTILITY(U,$J,358.3,30807,0)
 ;;=F33.9^^123^1534^13
 ;;^UTILITY(U,$J,358.3,30807,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30807,1,3,0)
 ;;=3^MDD,Recurrent,Unspec
 ;;^UTILITY(U,$J,358.3,30807,1,4,0)
 ;;=4^F33.9
 ;;^UTILITY(U,$J,358.3,30807,2)
 ;;=^5003537
 ;;^UTILITY(U,$J,358.3,30808,0)
 ;;=F33.0^^123^1534^10
 ;;^UTILITY(U,$J,358.3,30808,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30808,1,3,0)
 ;;=3^MDD,Recurrent,Mild
 ;;^UTILITY(U,$J,358.3,30808,1,4,0)
 ;;=4^F33.0
 ;;^UTILITY(U,$J,358.3,30808,2)
 ;;=^5003529
 ;;^UTILITY(U,$J,358.3,30809,0)
 ;;=F33.1^^123^1534^11
 ;;^UTILITY(U,$J,358.3,30809,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30809,1,3,0)
 ;;=3^MDD,Recurrent,Moderate
 ;;^UTILITY(U,$J,358.3,30809,1,4,0)
 ;;=4^F33.1
 ;;^UTILITY(U,$J,358.3,30809,2)
 ;;=^5003530
 ;;^UTILITY(U,$J,358.3,30810,0)
 ;;=F33.2^^123^1534^12
 ;;^UTILITY(U,$J,358.3,30810,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30810,1,3,0)
 ;;=3^MDD,Recurrent,Severe
 ;;^UTILITY(U,$J,358.3,30810,1,4,0)
 ;;=4^F33.2
 ;;^UTILITY(U,$J,358.3,30810,2)
 ;;=^5003531
 ;;^UTILITY(U,$J,358.3,30811,0)
 ;;=F33.3^^123^1534^7
 ;;^UTILITY(U,$J,358.3,30811,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30811,1,3,0)
 ;;=3^MDD,Recurrent w/ Psychotic Features
 ;;^UTILITY(U,$J,358.3,30811,1,4,0)
 ;;=4^F33.3
 ;;^UTILITY(U,$J,358.3,30811,2)
 ;;=^5003532
 ;;^UTILITY(U,$J,358.3,30812,0)
 ;;=F33.41^^123^1534^9
 ;;^UTILITY(U,$J,358.3,30812,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30812,1,3,0)
 ;;=3^MDD,Recurrent,In Partial Remission
 ;;^UTILITY(U,$J,358.3,30812,1,4,0)
 ;;=4^F33.41
 ;;^UTILITY(U,$J,358.3,30812,2)
 ;;=^5003534
 ;;^UTILITY(U,$J,358.3,30813,0)
 ;;=F33.42^^123^1534^8
 ;;^UTILITY(U,$J,358.3,30813,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30813,1,3,0)
 ;;=3^MDD,Recurrent,In Full Remission
 ;;^UTILITY(U,$J,358.3,30813,1,4,0)
 ;;=4^F33.42
 ;;^UTILITY(U,$J,358.3,30813,2)
 ;;=^5003535
 ;;^UTILITY(U,$J,358.3,30814,0)
 ;;=F34.8^^123^1534^6
 ;;^UTILITY(U,$J,358.3,30814,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30814,1,3,0)
 ;;=3^Disruptive Mood Dysregulation Disorder
 ;;^UTILITY(U,$J,358.3,30814,1,4,0)
 ;;=4^F34.8
 ;;^UTILITY(U,$J,358.3,30814,2)
 ;;=^5003539
 ;;^UTILITY(U,$J,358.3,30815,0)
 ;;=F32.8^^123^1534^1
 ;;^UTILITY(U,$J,358.3,30815,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30815,1,3,0)
 ;;=3^Depressive Disorder NEC
 ;;^UTILITY(U,$J,358.3,30815,1,4,0)
 ;;=4^F32.8
